Sign in
4

Changes in Ownership

SANGAMO THERAPEUTICS, INC Filed Acc 0001415889-25-005704

PRESIDENT, CEO AND DIRECTOR gave up 18,151 shares (to pay taxes)

  • PRESIDENT, CEO AND DIRECTOR acquired 375,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Macrae Sandy · PRESIDENT, CEO AND DIRECTOR

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Shares withheld for taxes : show line 1 in the form −7,488 $1.00 $7,488 2,088,511 D
2025-02-25 Shares withheld for taxes : show line 2 in the form −10,663 $0.96 $10,195 2,077,848 D
2025-02-25 Grant or award : show line 3 in the form +375,000 2,452,848 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-25 Grant or award : show line 4 in the form Stock Option (Right to Buy) +1,750,000 1,750,000 D
Loading xslF345X05/form4-02262025_100229.xml…